Shenzhen, China, 12 March 2024 – MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, proudly announces that its DNBSEQ-T20×2 ("T20") gene sequencer has been honored with the esteemed iF Design Award. The T20 has been lauded for its minimalist design, integrating distinguished aesthetics with cutting-edge technology, offering a redefined sequencing experience.

Powered by MGI DNBSEQ™ technology, T20, a high-throughput sequencer introduced in 2023, can support the simultaneous operation of 6 flow cells, enabling the completion of up to 50,000 whole genome sequencing cases per year. It has also set a new global record in sequencing instrument throughput and individual sequencing cost reduction, achieving whole genome sequencing for less than $100 per person, thus named a "Super Sequencing factory" for the industry as it reshapes the industry's ecosystem.

In conjunction with an all-in-one genome project toolkit, T20 can be applied across various domains, meeting the demands of ultra-high-throughput sequencing and facilitating research in population genomics, multi-omics, and STOmics, bringing a promising future for genetic technology development.

Established in 1953, the iF Design Awards are recognized internationally as one of the world's most prestigious design awards and are often referred to as the "Oscar of Design". It's the sixth time MGI has received the award. In 2019, MGI won iF Design Award for DNBSEQ-T7* and Benchtop sequencing lab DNBSEQ-E5*, and for Robotic Ultrasound System in 2017 and DNBSEQ-G99* in 2023.

 "We feel proud to receive the iF Design Award for T20 gene sequencing platform," said Duncan Yu, President of MGI, "This award is a testament to our commitment to benefit people around the world by developing superior life science tools and enhancing the cost-efficiency of application. We are proud of our design and look forward to continuing to deliver innovative solutions to our customers."

For more information about the DNBSEQ- T20×2 platform, please visit MGI's website.

About MGI

MGI Tech Co. Ltd. (or its subsidiaries, together referred to MGI), headquartered in Shenzhen, is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production and sales of sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers**, and its multi-omics platforms include genetic sequencing**, medical imaging, and laboratory automation. MGI's mission is to develop and promote advanced life science tools for future healthcare. For more information, please visit the MGI website or connect with us on Twitter, LinkedIn or YouTube.
*Products are provided for Research Use Only. Not for use in diagnostic procedures (except as specifically noted)